Clinical Trial Update: Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles [Phase 4]

View source ↗

Summary

This Phase 4 trial compares once-daily continuous Tobramycin Inhalation Powder to twice-daily dosing in cystic fibrosis. The study was terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Tobramycin Inhalation Powder (TIP) (tobramycin inhalation powder)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cystic Fibrosis | Phase 4 | Status: TERMINATED | Results posted: 2017-03-29